Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1996 Aug;89(8):436–442. doi: 10.1177/014107689608900806

Issues in the prevention of spina bifida.

C Bower 1, F J Stanley 1
PMCID: PMC1295884  PMID: 8795496

Full text

PDF
436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. J., Jr, Khoury M. J., Scanlon K. S., Stevenson R. E., Knight G. J., Haddow J. E., Sylvester G. C., Cheek J. E., Henry J. P., Stabler S. P. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology. 1995 May;51(5):311–317. doi: 10.1002/tera.1420510507. [DOI] [PubMed] [Google Scholar]
  2. Bower C. Folate and neural tube defects. Nutr Rev. 1995 Sep;53(9 Pt 2):S33–S38. [PubMed] [Google Scholar]
  3. Bower C., Stanley F. J. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust. 1989 Jun 5;150(11):613–619. doi: 10.5694/j.1326-5377.1989.tb136723.x. [DOI] [PubMed] [Google Scholar]
  4. Bower C., Stanley F. J. Periconceptional vitamin supplementation and neural tube defects; evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health. 1992 Apr;46(2):157–161. doi: 10.1136/jech.46.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bower C., Wald N. J. Vitamin B12 deficiency and the fortification of food with folic acid. Eur J Clin Nutr. 1995 Nov;49(11):787–793. [PubMed] [Google Scholar]
  6. Brown R. S., Di Stanislao P. T., Beaver W. T., Bottomley W. K. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol. 1991 May;71(5):565–568. doi: 10.1016/0030-4220(91)90363-h. [DOI] [PubMed] [Google Scholar]
  7. Bunduki V., Dommergues M., Zittoun J., Marquet J., Muller F., Dumez Y. Maternal-fetal folate status and neural tube defects: a case control study. Biol Neonate. 1995;67(3):154–159. doi: 10.1159/000244157. [DOI] [PubMed] [Google Scholar]
  8. Bunin G. R., Kuijten R. R., Buckley J. D., Rorke L. B., Meadows A. T. Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med. 1993 Aug 19;329(8):536–541. doi: 10.1056/NEJM199308193290804. [DOI] [PubMed] [Google Scholar]
  9. Butterworth C. E., Jr, Hatch K. D., Macaluso M., Cole P., Sauberlich H. E., Soong S. J., Borst M., Baker V. V. Folate deficiency and cervical dysplasia. JAMA. 1992 Jan 22;267(4):528–533. [PubMed] [Google Scholar]
  10. Butterworth C. E., Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr. 1989 Aug;50(2):353–358. doi: 10.1093/ajcn/50.2.353. [DOI] [PubMed] [Google Scholar]
  11. Carmel R. Requesting vitamin B12 and folate assays. Lancet. 1995 Oct 7;346(8980):973–973. [PubMed] [Google Scholar]
  12. Carolina R. A., Bloche M. G. Paying for undercompensated hospital care: the regressive profile of a "hidden tax". Health Matrix Clevel. 1992 Summer;2(2):141–165. [PubMed] [Google Scholar]
  13. Chan A., Robertson E. F., Haan E. A., Keane R. J., Ranieri E., Carney A. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. BMJ. 1993 Sep 18;307(6906):703–706. doi: 10.1136/bmj.307.6906.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clark N. A., Fisk N. M. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol. 1994 Aug;101(8):709–710. doi: 10.1111/j.1471-0528.1994.tb13190.x. [DOI] [PubMed] [Google Scholar]
  15. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991 Apr 25;324(17):1149–1155. doi: 10.1056/NEJM199104253241701. [DOI] [PubMed] [Google Scholar]
  16. Crane N. T., Wilson D. B., Cook D. A., Lewis C. J., Yetley E. A., Rader J. I. Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health. 1995 May;85(5):660–666. doi: 10.2105/ajph.85.5.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Czeizel A. E., Dudás I., Métneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet. 1994;255(3):131–139. doi: 10.1007/BF02390940. [DOI] [PubMed] [Google Scholar]
  18. Czeizel A. E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832–1835. doi: 10.1056/NEJM199212243272602. [DOI] [PubMed] [Google Scholar]
  19. Czeizel A. E. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ. 1993 Jun 19;306(6893):1645–1648. doi: 10.1136/bmj.306.6893.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. De Jong-Van den Berg L. T., Cornel M. C., Tymstra T., Buitendijk S. E. Folate prophylaxis in pregnancy. Lancet. 1995 Nov 4;346(8984):1227–1228. doi: 10.1016/s0140-6736(95)92931-2. [DOI] [PubMed] [Google Scholar]
  21. Dickinson C. J. Does folic acid harm people with vitamin B12 deficiency? QJM. 1995 May;88(5):357–364. [PubMed] [Google Scholar]
  22. Doyle W. Folic acid in prevention of neural tube defects. Lancet. 1995 Feb 11;345(8946):389–390. [PubMed] [Google Scholar]
  23. Elwood J. M. Can vitamins prevent neural tube defects? Can Med Assoc J. 1983 Nov 15;129(10):1088–1092. [PMC free article] [PubMed] [Google Scholar]
  24. Eskes T. K. Possible basis for primary prevention of birth defects with folic acid. Fetal Diagn Ther. 1994 May-Jun;9(3):149–154. doi: 10.1159/000263923. [DOI] [PubMed] [Google Scholar]
  25. Fraser F. C. Folic acid and neural tube defects. CMAJ. 1995 May 1;152(9):1380–1381. [PMC free article] [PubMed] [Google Scholar]
  26. Friel J. K., Frecker M., Fraser F. C. Nutritional patterns of mothers of children with neural tube defects in Newfoundland. Am J Med Genet. 1995 Jan 16;55(2):195–199. doi: 10.1002/ajmg.1320550209. [DOI] [PubMed] [Google Scholar]
  27. Gibberd F. B., Nicholls A., Wright M. G. The influence of folic acid on the frequency of epileptic attacks. Eur J Clin Pharmacol. 1981 Jan;19(1):57–60. doi: 10.1007/BF00558385. [DOI] [PubMed] [Google Scholar]
  28. HILL A. B. THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med. 1965 May;58:295–300. doi: 10.1177/003591576505800503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Heimburger D. C., Alexander C. B., Birch R., Butterworth C. E., Jr, Bailey W. C., Krumdieck C. L. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA. 1988 Mar 11;259(10):1525–1530. [PubMed] [Google Scholar]
  30. Khoury M. J., Gomez-Farias M., Mulinare J. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring? Am J Dis Child. 1989 Mar;143(3):333–337. doi: 10.1001/archpedi.1989.02150150091023. [DOI] [PubMed] [Google Scholar]
  31. Kirke P. N., Daly L. E., Elwood J. H. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child. 1992 Dec;67(12):1442–1446. doi: 10.1136/adc.67.12.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kirke P. N., Molloy A. M., Daly L. E., Burke H., Weir D. G., Scott J. M. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993 Nov;86(11):703–708. [PubMed] [Google Scholar]
  33. Laurence K. M., James N., Miller M. H., Tennant G. B., Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981 May 9;282(6275):1509–1511. doi: 10.1136/bmj.282.6275.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lindenbaum J., Healton E. B., Savage D. G., Brust J. C., Garrett T. J., Podell E. R., Marcell P. D., Stabler S. P., Allen R. H. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988 Jun 30;318(26):1720–1728. doi: 10.1056/NEJM198806303182604. [DOI] [PubMed] [Google Scholar]
  35. Lucock M. D., Wild J., Schorah C. J., Levene M. I., Hartley R. The methylfolate axis in neural tube defects: in vitro characterisation and clinical investigation. Biochem Med Metab Biol. 1994 Aug;52(2):101–114. doi: 10.1006/bmmb.1994.1040. [DOI] [PubMed] [Google Scholar]
  36. MacMahon M. Requesting vitamin B12 and folate assays. Lancet. 1995 Oct 7;346(8980):973–973. [PubMed] [Google Scholar]
  37. Marsack C. R., Alsop C. L., Kurinczuk J. J., Bower C. Pre-pregnancy counselling for the primary prevention of birth defects: rubella vaccination and folate intake. Med J Aust. 1995 Apr 17;162(8):403–406. doi: 10.5694/j.1326-5377.1995.tb139966.x. [DOI] [PubMed] [Google Scholar]
  38. Metz J. Folate, B12 and neural tube defects. Med J Aust. 1995 Sep 4;163(5):231–232. doi: 10.5694/j.1326-5377.1995.tb124555.x. [DOI] [PubMed] [Google Scholar]
  39. Mills J. L., McPartlin J. M., Kirke P. N., Lee Y. J., Conley M. R., Weir D. G., Scott J. M. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995 Jan 21;345(8943):149–151. doi: 10.1016/s0140-6736(95)90165-5. [DOI] [PubMed] [Google Scholar]
  40. Mills J. L., Rhoads G. G., Simpson J. L., Cunningham G. C., Conley M. R., Lassman M. R., Walden M. E., Depp O. R., Hoffman H. J. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. N Engl J Med. 1989 Aug 17;321(7):430–435. doi: 10.1056/NEJM198908173210704. [DOI] [PubMed] [Google Scholar]
  41. Milunsky A., Jick H., Jick S. S., Bruell C. L., MacLaughlin D. S., Rothman K. J., Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989 Nov 24;262(20):2847–2852. doi: 10.1001/jama.262.20.2847. [DOI] [PubMed] [Google Scholar]
  42. Mulinare J., Cordero J. F., Erickson J. D., Berry R. J. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988 Dec 2;260(21):3141–3145. [PubMed] [Google Scholar]
  43. Nelson-Piercy C., de Swiet M. Minimal compliance with Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol. 1995 Feb;102(2):171–171. doi: 10.1111/j.1471-0528.1995.tb09080.x. [DOI] [PubMed] [Google Scholar]
  44. Ralston A. J., Snaith R. P., Hinley J. B. Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants. Lancet. 1970 Apr 25;1(7652):867–868. doi: 10.1016/s0140-6736(70)91694-6. [DOI] [PubMed] [Google Scholar]
  45. Reggler J. Folic acid and the prevention of neural tube defects. Power of the state in attitudes to health has already expanded too much. BMJ. 1995 Jul 22;311(6999):256–256. doi: 10.1136/bmj.311.6999.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Reynolds E. H. How do anticonvulsants work? Br J Hosp Med. 1978 May;19(5):505–512. [PubMed] [Google Scholar]
  47. Romano P. S., Waitzman N. J., Scheffler R. M., Pi R. D. Folic acid fortification of grain: an economic analysis. Am J Public Health. 1995 May;85(5):667–676. doi: 10.2105/ajph.85.5.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Scott J., Weir D. G., Kirke P. N. Prevention of neural tube defects with folic acid a success but... QJM. 1994 Dec;87(12):705–707. doi: 10.1093/oxfordjournals.qjmed.a068887. [DOI] [PubMed] [Google Scholar]
  49. Sharpe G., Young G. Folic acid and the prevention of neural tube defects. Most pregnant women do not take folic acid. BMJ. 1995 Jul 22;311(6999):256–256. doi: 10.1136/bmj.311.6999.256b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Shaw G. M., Lammer E. J., Wasserman C. R., O'Malley C. D., Tolarova M. M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995 Aug 12;346(8972):393–396. doi: 10.1016/s0140-6736(95)92778-6. [DOI] [PubMed] [Google Scholar]
  51. Shaw G. M., Schaffer D., Velie E. M., Morland K., Harris J. A. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995 May;6(3):219–226. doi: 10.1097/00001648-199505000-00005. [DOI] [PubMed] [Google Scholar]
  52. Smith R. B., Davies N., Davies J. Prevention of neural tube defects. Lancet. 1994 Jan 8;343(8889):123–124. [PubMed] [Google Scholar]
  53. Smithells R. W., Sheppard S., Schorah C. J., Seller M. J., Nevin N. C., Harris R., Read A. P., Fielding D. W. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet. 1980 Feb 16;1(8164):339–340. doi: 10.1016/s0140-6736(80)90886-7. [DOI] [PubMed] [Google Scholar]
  54. Steegers-Theunissen R. P., Boers G. H., Trijbels F. J., Eskes T. K. Neural-tube defects and derangement of homocysteine metabolism. N Engl J Med. 1991 Jan 17;324(3):199–200. doi: 10.1056/NEJM199101173240315. [DOI] [PubMed] [Google Scholar]
  55. Sutcliffe M., Schorah C. J., Perry A., Wild J. Prevention of neural tube defects. Lancet. 1993 Nov 6;342(8880):1174–1174. doi: 10.1016/0140-6736(93)92158-p. [DOI] [PubMed] [Google Scholar]
  56. Sutcliffe M., Wild J., Perry A., Schorah C. J. Prevention of neural tube defects. Lancet. 1994 Dec 3;344(8936):1578–1578. doi: 10.1016/s0140-6736(94)90390-5. [DOI] [PubMed] [Google Scholar]
  57. Tolarova M., Harris J. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology. 1995 Feb;51(2):71–78. doi: 10.1002/tera.1420510205. [DOI] [PubMed] [Google Scholar]
  58. Vergel R. G., Sanchez L. R., Heredero B. L., Rodriguez P. L., Martinez A. J. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn. 1990 Mar;10(3):149–152. doi: 10.1002/pd.1970100303. [DOI] [PubMed] [Google Scholar]
  59. Wald N. J., Bower C. Folic acid and the prevention of neural tube defects. BMJ. 1995 Apr 22;310(6986):1019–1020. doi: 10.1136/bmj.310.6986.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Werler M. M., Shapiro S., Mitchell A. A. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993 Mar 10;269(10):1257–1261. [PubMed] [Google Scholar]
  61. Wilcken D. E., Wang X. L. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase. Lancet. 1996 Feb 3;347(8997):340–340. doi: 10.1016/s0140-6736(96)90526-7. [DOI] [PubMed] [Google Scholar]
  62. Wild J., Seller M. J., Schorah C. J., Smithells R. W. Investigation of folate intake and metabolism in women who have had two pregnancies complicated by neural tube defects. Br J Obstet Gynaecol. 1994 Mar;101(3):197–202. doi: 10.1111/j.1471-0528.1994.tb13109.x. [DOI] [PubMed] [Google Scholar]
  63. Yates J. R., Ferguson-Smith M. A., Shenkin A., Guzman-Rodriguez R., White M., Clark B. J. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet. 1987 May;31(5):279–287. doi: 10.1111/j.1399-0004.1987.tb02809.x. [DOI] [PubMed] [Google Scholar]
  64. van der Put N. M., Steegers-Theunissen R. P., Frosst P., Trijbels F. J., Eskes T. K., van den Heuvel L. P., Mariman E. C., den Heyer M., Rozen R., Blom H. J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995 Oct 21;346(8982):1070–1071. doi: 10.1016/s0140-6736(95)91743-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES